Physician profile
Jocelyn Ou
NPI 1225518996
$4,463.22
in general payments reported to CMS, 2019-2025
19 companies · $755 in 2025
The $755 reported for 2025 was more than what 86% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,720 · 2020: $29.82 · 2021: $233 · 2022: $418 · 2023: $267 · 2024: $41.20 · 2025: $755.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,063.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,063.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,499.61 | 2019-2025 | Rhopressa, Rocklatan, Simbrinza |
| Valley Contax, INC. | $1,110.02 | 2019 | |
| Novartis Pharmaceuticals Corporation | $319.12 | 2019-2023 | |
| Amgen INC. | $290.30 | 2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $232.07 | 2025 | Xdemvy |
| Visioneering Technologies, INC. | $195.70 | 2019 | |
| Bausch & Lomb Americas INC. | $134.29 | 2022-2025 | Miebo, Xiidra, Alden Corneal Gp |
| Allergan, INC. | $123.82 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $115.90 | 2019 | |
| Glaukos Corporation | $100.84 | 2021-2023 | |
| Oyster Point Pharma, INC. | $76.36 | 2022-2023 | Tyrvaya |
| Johnson & Johnson Vision Care, INC. | $76.22 | 2019 | |
| Coopervision INC. | $50.00 | 2019 | |
| Sun Pharmaceutical Industries INC. | $44.27 | 2020-2025 | |
| Abbvie INC. | $25.40 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $23.76 | 2021 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Thea Pharma INC. | $14.26 | 2025 | Iyuzeh |
| Rxsight INC | $14.04 | 2023 | Rxsight Light Adjustable Lens (Rxlal), Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jocelyn Ou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.